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Background: Recent reports on the growing HIV epidemic among men who have sex with men (MSM) in the EU/
EEA area were accompanied by an increase of reported HIV among MSM in Oslo, Norway in 2003. Our study with
data from 1995 to 2011 has described the recent trends of HIV among MSM in Norway and their socio-
demographic and epidemiological characteristics.
Methods: The data were collected from the Norwegian Surveillance System for Communicable Diseases. Cases
were described by age, place of infection, clinical presentation of HIV infection, STI co-infection and source partner.
We used simple linear regression to estimate trends over time.
Results: During the study period, 991 MSM, aged from 16 to 80 years, were newly diagnosed with HIV. No
significant trends over time in overall median age (36 years) were observed. Most of the MSM (505, 51%) were
infected in Oslo. In the years 1995-2002, 30 to 45 MSM were diagnosed with HIV each year, while in the years 2003-
2011 this increased to between 56 and 97 cases. The proportion of MSM, presenting with either AIDS or HIV illness,
decreased over time, while asymptomatic and acute HIV illness increased (p for trend=0.034 or less). STI co-infection
was reported in 133 (13%) cases. An overall increase of syphilis co-infected cases was observed (p for trend <0.001).
A casual partner was a source of infection in 590 cases (60%).
Conclusions: Though the increases described could be attributed to earlier testing and diagnosis, no change in the
median age of cases was observed. This indicates that it is likely that there has been an increase in HIV infections
among MSM in Norway since 2003. The simultaneous increase in STI co-infections indicates risky sexual behaviour
and a potential to spread both HIV and other sexually transmitted infections.
Keywords: HIV infection, Men who have sex with men, EpidemiologyBackground
Increases in HIV transmission among men who have sex
with men (MSM) have recently been reported from sev-
eral continents [1], including Europe. Data from 13
Western European countries suggested an increase of al-
most 100% from 1999 to 2006 [2]. In 2008, sex among
MSM was the predominant mode of transmission of
HIV infection in the EU/EEA area, when persons,
infected in and originating from countries with
generalised HIV epidemics were excluded [3].* Correspondence: irena.jakopanec@guest.arnes.si
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distribution, and reproduction in any mediumHIV infection has been a notifiable disease in Norway
since 1986 [4]. In the 1990s, the numbers of newly
reported HIV infections were relatively stable, but
Norway has experienced an increase in the number of
HIV infected since then. Up to the 31st December 2011,
heterosexual transmission was reported in 52% of all
reported cases and homosexual in 32% [5]. During this
time, immigration to Norway has greatly increased [6]
and immigrants, infected heterosexually in their country
of origin before arriving to Norway, now represent 36%
of all reported cases [5]. When it comes to transmission
of HIV in Norway, MSM have thus been the most vulner-
able population in the past decade. The first steep increase
of HIV infections among MSM in Oslo was noticed intral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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infected that same year or the year before [7].
Over the past few years, we have observed that MSM
with newly diagnosed gonorrhoea or syphilis in Norway are
increasingly co-infected with HIV [8]. This is particularly
worrisome, as sexually transmitted infections (STI) might
increase both susceptibility to HIV infection and enhance
HIV transmission from HIV positives [9].
In order to gain a better insight into the development of
the HIV epidemic among MSM in Norway, we aimed to
describe the HIV diagnosed MSM over a seventeen year
period, using demographic and epidemiological data. Due
to an increase in HIV diagnosed MSM in 2003 [7], we were
especially interested to find the differences between those
MSM infected before 2003 and those infected after 2003.
Methods
Free HIV testing is available at various settings including
general practitioners, hospitals, youth clinics and STI clinics
in Norway and any HIV positive test has to be confirmed
through a reference laboratory. All five reference laborator-
ies are obliged, by law [10] to report positive results an-
onymously to the Norwegian Institute of Public Health
(NIPH) [4] when a new HIV diagnosis in Norway is con-
firmed. Then, a laboratory fills out a two-part reporting
form with a unique reference number. The laboratory sends
one part of the form to NIPH and the other part, carrying
the same reference number, to the referring clinician, who
provides more detailed data, including epidemiological data
of the patient to the NIPH. Clinicians are also obliged by
law [10], to conduct contact tracing for HIV. NIPH con-
tacts the clinicians who fail to submit their part of the form
within a month or who send an incomplete report [4].
This study is based on the Norwegian Surveillance Sys-
tem for Communicable Diseases database, managed at
NIPH. From the database, we extracted reports on males,
who reported being infected by another man (hereafter
MSM cases) and were diagnosed in the years 1995 - 2011.
Demographic data on each patient include gender, month
and year of birth, county of residence and country of birth.
A variety of epidemiological data are collected in addition,
such as: presumed transmission route, time and place of in-
fection, indications for HIV test, date of a previous (most
recent) negative HIV test, clinical presentation (AIDS was
defined according to the 1993 European AIDS definition in
the study population, [11]), relationship to the source part-
ner, place of infection, diagnostic site and STI infections,
concurrently existing with HIV infection diagnosed (STI
co-infections).
For our analyses, we grouped categories of source partner
“husband or cohabitant” (58 cases) and “steady partner”
(108 cases) into a common category of steady partners. Age
was grouped into four categories and county of residence
into four health regions. Immigrant background wasassigned to first and second generation immigrants and
those, adopted from abroad.
Among several potential co-existing STIs, only one is
recorded at NIPH, using hierarchical criteria (1. syphilis, 2.
gonorrhoea etc.). A HIV positive patient, who was also
positive for Chlamydia and early syphilis (primary, second-
ary and early latent stage), will thus only have early syphilis
recorded in addition to HIV.
A date of infection is estimated from laboratory results,
previous negative tests and patients’ information. If a previ-
ous negative HIV test date is the only information available,
date of infection is assigned as the midpoint of the period
between that test and the first positive test [4].
Cases with “probable” year of infection had been
diagnosed within three years and fulfilled the following cri-
teria: 1. exact date of infection was known, or 2. clinical
presentation as an acute HIV infection, supported by either
laboratory evidence (sero-conversion) or anamnestic data,
or 3. a negative test, no older than three years, was avail-
able, or 4. a clinician evaluated the anamnestic data on time
of infection to be reliable. If these additional criteria were
not fulfilled, but a date of infection was estimated, the cases
had “uncertain” year of infection.
Among 252 cases, where the available information did
not allow an estimate of the year of infection, we used clin-
ical presentation at diagnosis, assigning 10 years to those
with AIDS (median AIDS incubation time, N=53) and 3
months to those with acute HIV (N=1) [12], assigning all
these to the “uncertain” year of infection group. The
remaining 198 cases with asymptomatic HIV and HIV
illness were excluded from estimates of time gap between
year of infection and year of diagnosis.
We performed statistical analyses with Stata/SE 11.1
(Stata Corp., TX, USA). We calculated frequency distribu-
tion for descriptive analyses. We used linear regression ana-
lysis to estimate the trends over time (for STI co-infection
this was only possible for syphilis). Given that the data be-
tween subsequent years may be correlated and the variabil-
ity between the years may not be constant over time, the
regression coefficients and their 95% confidence intervals
(CI) were calculated using the Newey-West procedure.
In order to understand the differences between MSM,
infected with HIV earlier in our study period compared to
the period after the increase in 2003, we studied factors
associated with “diagnosed in the period 2003-2011”
(compared to diagnosed in the period 1995-2002) by
Poisson regression with robust variance estimates. Crude
and adjusted prevalence ratios (PR) with 95% CI were
calculated. If there was zero variance in a category, we
excluded this category from the analysis.
Results
In the period 1995-2011, 991 men, infected by another
man, were newly diagnosed with HIV infection in Norway.
Jakopanec et al. BMC Public Health 2013, 13:144 Page 3 of 10
http://www.biomedcentral.com/1471-2458/13/144While no significant trend among cases was observed until
2002, the 2003-2011 period had a significant increasing
trend of HIV diagnoses among MSM (p for trend <0.001,
Figure 1).
The MSM were from 16 to 80 years old when diagnosed.
Overall median age was 36 years (range 33-38.5 years) and
interquartile range 30 – 44 years. No apparent trend in me-
dian age was observed, except for the period 1997 – 2002
(Figure 2).
Men with immigrant background represented 21% (205),
and men on a temporary visit to Norway, represented 4%
(37). Thus, a large majority were permanent residents of
Norway, mostly residents of Oslo municipality (666, 67%),
born in Norway (Table 1). The two other most frequent
countries of birth were Sweden (3%) and Thailand (3%).
Just above half of the cases (505, 51%) were infected in Oslo
and 140 (14%) in the rest of Norway.
For those who were infected abroad (248, 25%), predom-
inant countries of HIV acquisition were Thailand (34 cases),
Spain (33), USA (26 cases) and Germany (23 cases). Some
(109, 11%) could not identify where the infection was
acquired. Among those infected abroad, 39 had tested posi-
tive prior to arrival in Norway. Among 251 MSM, born
abroad, 105 acquired HIV infection abroad, compared to
143 out of 740 MSM, born in Norway. Their median age at
diagnosis was lower than for Norwegian born men (31
years vs. 38 years).
Half of the cases were infected less than a year prior
to being diagnosed (Table 1, Figure 1). The increase in
infections in 2003 and 2004 (Figure 1) coincides with an
increase of cases, infected by a casual partner (p for0
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Figure 1 Number of MSM diagnosed with HIV infection in 1995-2011
year and the estimated year of infection (“yeargap”).trend <0.001) (Figure 3). The majority of cases were
asymptomatic at the time of diagnosis (597, 60%, Figure 4).
Furthermore, the proportion of MSM presenting with ei-
ther AIDS or HIV illness, decreased over time, however,
the proportion of both asymptomatic and those with acute
HIV illness increased (all with p for trend=0.034 or less).
Of the 133 (13%) cases with concurrent HIV and STI
infections, syphilis was reported in 50 (3%). Among the
remaining 83, 29 had gonorrhoea. Of those 54, who had
neither syphilis or gonorrhoea, 21 had hepatitis B, 16
had Chlamydia, 6 had genital warts, 5 had genital herpes
and 6 had ”other, unspecified STI”.
From 1995 to 1999, one HIV and syphilis co-infection
among MSM was reported (in 1998). In 2000, a year
after an outbreak of syphilis among MSM in Norway [8],
5 cases (15.6% of all HIV MSM cases that year) with co-
infection were reported. From 2001, the numbers of
HIV and syphilis co-infected MSM vary (0-9 cases, 0-9%
of all HIV cases), but there is an overall increase of syph-
ilis co-infected cases (p for trend <0.001). The number
of MSM with any other STI co-infection (excluding
syphilis), also increased in time (p for trend = 0.016,
lowest 2 in 1998, highest 13 in 2010).
In the crude analysis, MSM diagnosed in the years 2003-
2011 were more likely to live in Mid-Norway, were tested
at their own request (compared to contact tracing) when
found positive, and were more likely to have been tested be-
fore compared to those, diagnosed in 1995-2002. MSM
diagnosed in 2003-2011 were also less likely to have been
diagnosed more than 3 years since infection, to have an un-
known year of infection and to be tested at a hospital or03 2004 2005 2006 2007 2008 2009 2010 2011
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Figure 2 Median age of MSM at the time of HIV diagnosis with interquartile range (boxes) and 10th and 90th age percentile in
1995-2011 in Norway, by year of diagnosis.
Jakopanec et al. BMC Public Health 2013, 13:144 Page 4 of 10
http://www.biomedcentral.com/1471-2458/13/144outpatient clinic (compared to a general practitioner’s
office). After adjustment for other factors (all listed in the
Table 1), findings were similar, and in addition, MSM
diagnosed in 2003-2011 seemed to be more likely born
abroad compared to those, diagnosed in 1995-2002. The
results were significant for MSM from Asia and suggested
similar effect for MSM from other countries of Europe
(p=0.051), Africa (p=0.055) and North America (p=0.090).
A “probable” year of infection was available for 479
(48 % of total sample) cases and an “uncertain” year of
infection for a further 314 (32 %) cases (Figure 5). The
number of HIV infections increased markedly in 2003 and
remained higher afterwards. The mean time between diag-
nosis and infection for these 793 (80%) of cases was 7.1
months (interquartile range 2.7 - 23.2). In 2003, the number
of cases infected more than doubled compared to a year be-
fore (from 27 to 63) and remained at high levels afterwards.
Discussion
We have observed an increase in number of HIV diagnoses
among MSM in Norway in recent years, particularly after
2002. The majority of MSM were infected in Oslo and they
were of Norwegian origin. Although HIV is diagnosed
mainly in asymptomatic MSM, our results suggest that
most of the cases diagnosed after 2002, have been infected
less than a year before being diagnosed. We observed a
simultaneous increase of STI co-infections, which is worri-
some, as there is a potential for spread of both HIV and
other STI.The possibility for NIPH to send a reminder to the diag-
nosing clinicians, if they fail to report a newly identified
HIV infection, contributes to a high completeness of infor-
mation [4]. There were no changes in the reporting system
in our study period and reporting delays are rare in Norway
[4]. Due to anonymous reporting, cases could be reported
twice if they are re-tested; however, laboratories do check
for duplicates in the same region before submitting a report
and further efforts to detect and remove duplicates are
done at NIPH [4]. It is worth emphasizing that all risk be-
haviour data, obtained by clinicians from their patients,
such as, for example, presumed transmission route, HIV in-
fection source partner and other risk factors for HIV trans-
mission (for example, injecting drug use), may be subject to
recall and reporting biases. Since some MSM might not be
open with their doctor about the way they were infected,
we may have missed some cases which have been classified
in other transmission groups. As the system records any in-
fection not reported previously, the HIV positive person
who immigrated to Norway is also included, if they were
tested in Norway (44 in our study population). Merging
STI into a common outcome has its limitations, as some
STIs might be recent (acute) and others, such as hepatitis
B, could be chronic with different risk factors.
The HIV surveillance data monitor the incidence of new
diagnoses rather than new infections and will be thus largely
influenced by HIV testing uptake. Since specific tests to dis-
tinguish between the early and late infection [13] are not
yet routinely applied in HIV diagnostics and reporting in
Norway, it is difficult to distinguish between the current
Table 1 Selected characteristics of HIV positive MSM who were diagnosed in Norway in 1995-2011, and factors
associated with having been diagnosed in the years 2003-2011 compared to 1995-2002
Demographic,
epidemiological
and other possibly
associated factors
Total sample Diagnosed in the years
2003-2011
Diagnosed in the years
1995-2002
Comparison of diagnosed in the years
2003-2011 vs. diagnosed in 1995-2002
N=991 (%) N= 713 (%) N= 278 (%) Crude PR*
[95% CI]
Adjusted PR**
[95% CI]
p for
trend
Age groups (years)
16-24 73 (7.4) 56 (7.8) 17 (6.1) ref. group ref. group 0.418
25-34 362 (36.5) 266 (37.3) 96 (34.5) 1.0 [0.8-1.1] 1.0 [0.9-1.1]
35-44 323 (32.6) 221 (31.0) 102 (36.7) 0.9 [0.8-1.0] 1.0 [0.8-1.1]
≥ 45 233 (23.5) 170 (23.8) 63 (22.7) 0.9 [0.8-1.1] 1.1 [1.0-1.3]
Place of birth
Norway 740 (74.7) 523 (73.3) 217 (78.1) ref. group ref. group
Africa 23 (2.3) 18 (2.5) 5 (1.8) 1.1 [0.9-1.4] 1.3 [1.0-1.6]
Asia 64 (6.5) 50 (7.0) 14 (5.0) 1.1 [1.0-1.3] 1.2 [1.0-1.4]
Europe, other 92 (9.3) 71 (10.0) 21 (7.6) 1.1 [1.0-1.2] 1.1 [1.0-1.3]
North America 13 (1.3) 11 (1.5) 2 (0.7) 1.2 [0.9-1.5] 1.2 [1.0-1.6] NA
South/Mid America 59 (5.6) 40 (5.6) 19 (6.8) 0.9 [0.8-1.1] 1.0 [0.8-1.2]
Health region of residence in Norway
South-East*** 842 (85.0) 602 (84.4) 240 (86.3) ref. group ref. group NA
West 86 (8.7) 58 (8.1) 28 (10.1) 0.9 [0.8-1.1] 0.9 [0.8-1.2]
Mid-Norway 39 (4.0) 35 (4.9) 4 (1.4) 1.2 [1.1-1.4] 1.3 [1.1-1.5]
North 24 (2.4) 18 (2.5) 6 (2.2) 1.0 [0.8-1.3] 1.0 [0.8-1.3]
Year gap****
< 1 year 498 (50.2) 389 (54.6) 109 (39.2) ref. group ref. group 0.001
1-3 years 157 (15.8) 118 (16.5) 39 (14.0) 1.0 [0.9-1.1] 1.0 [0.8-1.1]
>3 years 84 (8.5) 41 (5.7) 43 (15.5) 0.6 [0.5-0.8] 0.6 [0.5-0.8]
Unknown 252 (25.4) 165 (23.1) 87 (31.3) 0.8 [0.8-0.9] 0.7 [0.6-0.9]
Reason for HIV test
Contact tracing 109 (11.0) 68 (9.5) 41 (14.8) ref. group ref. group NA
Own request 328 (33.1) 261 (36.6) 67 (24.1) 1.3 [1.1-1.5] 1.3 [1.1-1.5]
Blood donor 1 (0.1) 0 1 (0.4) excluded excluded
Immigrant 11 (1.1) 7 (1.0) 4 (1.4) 1.0 [0.6-1.6] 1.0 [0.6-1.7]
Symptoms 347 (35.0) 249 (35.0) 98 (35.3) 1.1 [1.0-1.3] 1.2 [1.0-1.4]
Unspecified 195 (20.0) 128 (18.0) 67 (24.1) 1.1 [0.9-1.3] 1.1 [0.9-1.3]
Source partner
Steady 166 (16.7) 117 (16.4) 49 (17.6) ref. group ref. group NA
Casual 590 (59.5) 442 (62.0) 148 (53.2) 1.1 [1.0-1.2] 1.1 [1.0-1.2]
Commercial sex
worker
3 (0.3) 3 (0.4) 0 excluded excluded
Other/unknown 232 (23.4) 151 (21.2) 81 (29.1) 0.9 [0.8-1.1] 1.0 [0.9-1.2]
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Table 1 Selected characteristics of HIV positive MSM who were diagnosed in Norway in 1995-2011, and factors
associated with having been diagnosed in the years 2003-2011 compared to 1995-2002 (Continued)
Diagnosed by
GP or private
specialist
412 (41.6) 315 (44.2) 97 (34.9) ref. group ref. group NA
Youth/STI clinic 320 (32.3) 329 (32.1) 91 (32.7) 0.9 [0.9-1.0] 0.9 [0.9-1.0]
Hospital/ outpatient
dept.
247 (24.9) 163 (22.7) 85 (30.6) 0.9 [0.8-0.9] 0.9 [0.8-1.0]
Other 12 (1.2) 7 (1.0) 5 (1.8) 0.8 [0.5-1.2] 0.8 [0.5-1.3]
Previous negative test
No previous test 336 (33.9) 221 (31.0) 115 (41.4) ref. group ref. group NA
Tested before 588 (59.3) 425 (59.6) 163 (58.6) 1.1 [1.0-1.2] 0.9 [0.9-1.0]
Unknown 67 (6.8) 67 (9.40) 0 excluded excluded
STI co-infection
None reported 858 (86.6) 617 (86.5) 241 (86.7) ref. group ref. group NA
Any 133 (13.4) 96 (13.5) 37 (13.3) 1.0 [0.9-1.1] 1.1 [0.9-1.2]
* PR – prevalence ratio.
** adjusted for all the factors, listed in the Table.
**includes Oslo.
***time between infection and diagnosis in years.
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covered in the previous years.
While no systematically collected data on testing activity
among MSM in Norway in our study period exist, some
data suggest satisfactory testing rates. In a 2003 study where
MSM were approached at several gay venues in Oslo, 87%
have answered they had ever been tested for HIV (76% in
1990, 80% in 1998) [14]. In a 2007 survey in Norwegian
language that recruited respondents among visitors to a gay
Internet site [15], 69% of 2598 responding MSM reported
that they had been tested for HIV at least once and the pro-
portion who tested positive was 4% (data not published). In
a more recent internet based cross-European MSM survey
from 2010, 67% of responding MSM in Norway reported
having received the HIV test result at least once, of which
3.5% were positive [16]. A third has received the result of
their HIV test in the last 12 months in 2010 survey
[17] and 37% in 2007 survey (data not published).
We can conclude testing rates among MSM in Norway
are satisfactory, though we should be aware the test
uptake is likely lower among those who are infected
[18].
Though information on time of infection is subject to
bias, the assumption that there is an actual increase in
recently infected cases is supported by the median age
showing no significant increase over time [19]. Further-
more, results from the internet based behavioural survey
in 2010 have revealed worrisome risky behaviour, as 54%
of MSM respondents who had engaged in sex with a
non-steady partner had had anal intercourse without a
condom in the past year and more than 30% said theydid not use a condom the last time they had anal sex
with a casual partner [16].
In order to clarify the described increasing trends, our
findings call for improvements in HIV monitoring in
Norway. Regular monitoring of HIV prevalence using an-
onymous unlinked studies, as well as monitoring testing
trends and MSM behaviour in Norway are recommended.
Introduction of CD4 count in surveillance data and
approaches to reduce potential double-reporting (such as
Soundex code) should be considered, as more and more
MSM live with HIV in Norway and the risk of double
reporting after re-testing is increasing.
We aimed to estimate year of infection from the informa-
tion available, though important limitations (see above)
with this approach exist, since for 20% of diagnosed cases
the year of infection could not be estimated. Thus, our time
intervals between infection and first diagnosis are
underestimated as those excluded 20% are likely to have an
interval longer than 7 months. A French study based on
surveillance data from 2004-2007 reported much longer
time (median 25 months, interquartile range 5-55) [12].
Had we assigned an overestimate of 10 years to the
remaining 20% of cases, our median would increase to 12
months, indicating MSM in Norway are on average being
diagnosed earlier than French.
The surveillance systems of new HIV diagnoses in
European countries have varying characteristics, which
makes it difficult to compare our results, however; similar
increasing trends in diagnoses of HIV infections among
MSM of all age groups have recently been reported in
Belgium (1999-2008) [20], Germany (1999-2005) [21] and
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Figure 3 Number of MSM diagnosed with HIV infection in 1995-2011 in Norway, by year of diagnosis and assumed source partner.
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this, data from London and the Amsterdam STI clinic
(1991-2004) suggested that an increase in HIV incidence
was observed specifically among MSM aged 35 years and
older [22,23]. Median age in our study seemed to be simi-
lar to the one in Belgium and Denmark (1990-2005) [24]
with median age 37.
Similar to our findings, in Belgium, 11% of HIV posi-
tive MSM had an STI co-infection in 2008 (data pro-
vided by participating AIDS Reference Centers) [20]. In
the period 2003-2007, as many as 31% of the 1462 newly
HIV diagnosed MSM in Spain (data from 19 HIV/STI0
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Figure 4 Number of MSM diagnosed with HIV infection in 1995-2011clinics) were diagnosed with a concurrent STI [25]. An
increase from 5% (2001) to 7% (2003) in concurrent syphilis
and HIV was reported from Germany [26]. Syphilis
outbreaks including HIV positive MSM were described in
metropolitan areas of Western Europe (London, Paris,
Dublin, Hamburg) with MSM who were mostly aware of
their HIV status [27].
HIV was the most frequently reported STI among MSM
in Norway in 2006 [8,28]. With rising HIV prevalence,
MSM are more likely to have sex with an HIV positive man
than a man with any other acute STI [29]. In addition, the
prevalence of STI, which may increase the risk of HIV3 2005 2007 2009 2011
in Norway, by year of diagnosis and clinical symptoms.
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Figure 5 Number of MSM diagnosed with HIV infection in 1995-2011 in Norway, by their estimated year of infection (bars) (N=793)
and by year of diagnosis (line) (N=991). For the incidence bars, we excluded 198 cases with unknown year of infection and grouped 31 cases
with uncertain year of infection before 1990 in one bar. Note that existing bars will increase in the coming years as new cases infected in those
years are diagnosed, especially in the most recent years. The incidence bars for the years before 1995 do not include those, diagnosed
before 1995.
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HIV transmission has been evaluated as similar to that of
the pre-HAART era [30]. Primary HIV infection may have
a larger role in the dynamics of HIV transmission than
previously assumed, due to a higher viral load and higher
infectiousness [31]. Our results suggest similar trends in
Norway.
HIV transmission is predominantly affecting domestic-
born MSM [20,24,32], however, similar to other Western
countries, immigration has more than doubled in Norway
since 2000[33] and foreign born MSM are becoming more
represented in the recent years. Foreign born MSM are a
“difficult to reach”, heterogeneous and vulnerable popula-
tion, likely diagnosed younger than domestic-born MSM
[32]. According to guidelines issued by the Norwegian
Directorate of Health, immigrants from high HIV prevalent
areas should be offered a free confidential HIV test [34]
and support and treatment, if found positive. Nonetheless,
less than 1% of MSM were diagnosed due to immigrant
screening in our study, which is low compared to the group
of heterosexuals, infected before arrival to Norway, who
represent more than a third of all newly diagnosed HIVcases in Norway [16]. General practitioners should be
aware that some men might be reluctant to provide
details of their sexual behaviour to their clinician,
particularly if they originate from cultures, where such
behaviour is not acceptable. Specific preventive and
testing measures, targeted at foreign born MSM, should be
evaluated.
Those diagnosed in the years 2003-2011, were more
likely to be tested at their own request compared to con-
tact tracing and less likely to be diagnosed at hospital or
outpatient clinic than by their general practitioner. With a
simultaneous decrease of AIDS and HIV illness, this might
have been the effect of a 2005 recommendation to general
practitioners for annual HIV and STI testing of MSM in
Norway [35] and other MSM targeted public health
campaigns, encouraging HIV testing. Thus, risky behaviour
among MSM, might have been accompanied by improved
awareness on importance of testing and early capture of
infections. We concur with the recommendations from
2005 and emphasize the need to target MSM with immi-
grant background, as well as to conduct thorough partner
notification in the general practitioner’s setting.
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MSM around Europe and a coordinated approach in
HIV monitoring, prevention and control, should be
complemented with identification of new prevention
strategies. In the light of failing preventive measures (such
as promotion of safe sex practices and condom use), pre-
exposure prophylaxis is a promising biomedical interven-
tion, however still controversial due to possible side effects
on healthy men, poor adherence among HIV negative,
costs, change in sexual behaviour and resistance issues to
name a few [36,37]. Further studies are on the way to evalu-
ate the effectiveness of this approach [37]. Effectiveness of
male circumcision on HIV transmission among MSM
remains unknown [38].
Reasons why those living in Mid-Norway are more fre-
quent among cases from 2003-2011 are not clear. Recently,
rapid testing has become available countrywide, in both
health centers and specialized clinics, as well as in outreach
centers. In the latter, this is an assumed low threshold offer
that might increase testing uptake among high risk MSM.
It remains unanswered if current healthcare services are
sufficiently targeting foreign born MSM with testing and
information on STI prevention, though this low threshold
offer could make a difference.
Conclusions
Our data suggest continuing spread of HIV among MSM
in Norway. On average, MSM are being diagnosed early
after infection, however an increasing proportion are
co-infected with an STI. This calls for prompt and effective
preventive measures as many past preventive efforts seem
to have been insufficient or failing. At the same time,
current monitoring of HIV infections among MSM has
many limitations. In the light of the increase in HIV diag-
noses among MSM, this calls for urgent improvements and
more research on HIV prevalence, regular testing activity
and risky behaviour in this population.
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